LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

BioParadox

Point-of-care biologic, platelet-rich plasma-based treatments for cardiovascular disease and intermittent claudication.

Get a Demo and See the Full Profile

Get a demo today to see profiles of BioParadox plus 6116 other startups.

Learn More About BioParadox

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More